liraglutide
Coverage of liraglutide in the Nexus archive.
- Which GLP-1 works best? New meta-study puts them head-to-head
A new meta-study compared three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza). The study evaluated their effectiveness in a head-to-head analysis.
- Which GLP-1 works best? New meta-study puts them head-to-head
A new meta-study compared three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza).
- Which GLP-1 works best? New meta-study puts them head-to-head
A new meta-study compared three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza) to determine their effectiveness.
- Popular weight-loss drugs linked to unexpected male fertility benefit
GLP-1 weight-loss drugs may improve male fertility by enhancing testosterone levels and semen quality in obese men with low testosterone. A review of five trials found no suppression of male reproductive hormones and potential benefits for metabolic health, though more research is needed.
- Ozempic users may be making a major weight-loss mistake, new study suggests
A new study suggests that adults taking GLP-1 medications like Ozempic or Wegovy for weight loss are significantly reducing their physical activity, with decreases in daily steps and moderate-to-vigorous exercise. Researchers emphasize that exercise remains essential for preserving strength and long-term health when using these drugs, despite the observed decline in activity.
- Guts may hold the key to happiness
New research on mouse gut microbiomes suggests GLP-1 drugs like Ozempic may reduce depression and anxiety symptoms by altering gut bacteria, specifically increasing Lactobacillus delbrueckii, which produces stress-calming compounds. The study highlights a brain-gut connection linking these diabetes/weight-loss drugs to mood regulation.